145 related articles for article (PubMed ID: 21263150)
1. Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.
Fatrai S; Wierenga AT; Daenen SM; Vellenga E; Schuringa JJ
Blood; 2011 Mar; 117(12):3320-30. PubMed ID: 21263150
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation.
Wierenga AT; Vellenga E; Schuringa JJ
Blood; 2010 Jun; 115(22):4367-76. PubMed ID: 20339093
[TBL] [Abstract][Full Text] [Related]
3. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
Schepers H; van Gosliga D; Wierenga AT; Eggen BJ; Schuringa JJ; Vellenga E
Blood; 2007 Oct; 110(8):2880-8. PubMed ID: 17630355
[TBL] [Abstract][Full Text] [Related]
4. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.
Wierenga AT; Schepers H; Moore MA; Vellenga E; Schuringa JJ
Blood; 2006 Jun; 107(11):4326-33. PubMed ID: 16455947
[TBL] [Abstract][Full Text] [Related]
5. Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels.
Wierenga AT; Vellenga E; Schuringa JJ
Mol Cell Biol; 2008 Nov; 28(21):6668-80. PubMed ID: 18779318
[TBL] [Abstract][Full Text] [Related]
6. Steady state peripheral blood provides cells with functional and metabolic characteristics of real hematopoietic stem cells.
Bourdieu A; Avalon M; Lapostolle V; Ismail S; Mombled M; Debeissat C; Guérinet M; Duchez P; Chevaleyre J; Vlaski-Lafarge M; Villacreces A; Praloran V; Ivanovic Z; Brunet de la Grange P
J Cell Physiol; 2018 Jan; 233(1):338-349. PubMed ID: 28247929
[TBL] [Abstract][Full Text] [Related]
7. Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5.
Li G; Wang Z; Miskimen KL; Zhang Y; Tse W; Bunting KD
PLoS One; 2010 Feb; 5(2):e9152. PubMed ID: 20161778
[TBL] [Abstract][Full Text] [Related]
8. Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.
Han L; Wierenga AT; Rozenveld-Geugien M; van de Lande K; Vellenga E; Schuringa JJ
PLoS One; 2009 Nov; 4(11):e7989. PubMed ID: 19956772
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
10. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
11. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells.
Rentas S; Holzapfel N; Belew MS; Pratt G; Voisin V; Wilhelm BT; Bader GD; Yeo GW; Hope KJ
Nature; 2016 Apr; 532(7600):508-511. PubMed ID: 27121842
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.
Kato Y; Iwama A; Tadokoro Y; Shimoda K; Minoguchi M; Akira S; Tanaka M; Miyajima A; Kitamura T; Nakauchi H
J Exp Med; 2005 Jul; 202(1):169-79. PubMed ID: 15998795
[TBL] [Abstract][Full Text] [Related]
13. Herbal cocktail ka-mi-kae-kyuk-tang stimulates mouse bone marrow stem cell hematopoiesis and janus-activated kinase 2/signal transducer and activator of transcription 5 pathway.
Lee JE; Seo I; Jeong SJ; Koh W; Jung JH; Kwon TR; Lee HJ; Han I; Lee HJ; Lee EO; Kim SH; Jung HJ; Lu J; Kim SH
Am J Chin Med; 2011; 39(6):1235-52. PubMed ID: 22083993
[TBL] [Abstract][Full Text] [Related]
14. Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to
Porter SN; Cluster AS; Yang W; Busken KA; Patel RM; Ryoo J; Magee JA
Elife; 2016 Nov; 5():. PubMed ID: 27879203
[TBL] [Abstract][Full Text] [Related]
15. Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement.
Wang Z; Li G; Tse W; Bunting KD
Blood; 2009 May; 113(20):4856-65. PubMed ID: 19258595
[TBL] [Abstract][Full Text] [Related]
16. Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
Liu F; Kunter G; Krem MM; Eades WC; Cain JA; Tomasson MH; Hennighausen L; Link DC
J Clin Invest; 2008 Mar; 118(3):946-55. PubMed ID: 18292815
[TBL] [Abstract][Full Text] [Related]
17. Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells.
Bradley HL; Hawley TS; Bunting KD
Blood; 2002 Dec; 100(12):3983-9. PubMed ID: 12393407
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of HIF2α during iron deficiency-associated megakaryocytic differentiation.
Jimenez K; Khare V; Evstatiev R; Kulnigg-Dabsch S; Jambrich M; Strobl H; Gasche C
J Thromb Haemost; 2015 Jun; 13(6):1113-27. PubMed ID: 25715026
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
20. Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3(+)-mediated leukemic phenotype.
Müller TA; Grundler R; Istvanffy R; Rudelius M; Hennighausen L; Illert AL; Duyster J
Leukemia; 2016 Aug; 30(8):1725-33. PubMed ID: 27046463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
